iRhythm Holdings Inc. Common Stock (IRTC)
Stock · NASDAQ · Health Care
$108.66as of 10/16/2026
Price chart
Active signals
IRTC Signal Track Record
How signals performed across all stocks →What IRTC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | -2.0% | 43% | September 23, 2026 |
| Bollinger Band Breakdown | 23 | +3.5% | 61% | October 7, 2026 |
| Bollinger Band Breakout | 21 | -5.2% | 33% | July 1, 2026 |
| 200-Day Moving Average TouchActive now | 13 | -7.7% | 38% | February 3, 2026 |
| Any 20-session window (baseline) | -0.3% | 48% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About IRTC
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also prov…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 2,400
- Website
- www.irhythmtech.com/
Fundamentals
- 1-day range
- $106.21$109.45
- Market cap
- $4.21B
- P/E (trailing)
- —
- P/E (forward)
- 85.33
- EPS (trailing)
- $-0.43
- Dividend yield
- —
- Beta
- 1.49
- Avg. volume
- 567.0K
How iRhythm Holdings Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 19, 2026 · via SEC EDGAR / Finnhub
Forecasts
14 analyst ratings
iRhythm Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- IRTCiRhythm Holdings Inc. Common Stock$108.66▼ 0.63%Market cap $4.21BP/E —$100.7$212
- ICUIICU Medical Inc. Common Stock$162.99▼ 2.54%Market cap $4.16BP/E 139.19$113.37$192.85
- NVSTEnvista Holdings Corporation Common Stock$22.9▼ 2.55%Market cap $4.46BP/E 39.56$18.77$30.42
- HAEHaemonetics Corporation Common Stock$118.28▼ 2.48%Market cap $3.86BP/E 56.08$48.17$121.19
- MMEDMiniMed Group Inc. Common Stock$17.49▼ 2.83%Market cap $5.17BP/E —$10.65$24.43
- MMSIMerit Medical Systems Inc. Common Stock$89.2▼ 0.41%Market cap $5.24BP/E 36.33$59.74$94.75
- PLSEPulse Biosciences Inc Common Stock (DE)$44.43▼ 2.54%Market cap $2.65BP/E —$12.56$58.9
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IRTC iRhythm Holdings Inc. Common Stock | $4.21B | — | $108.66 | ▼ 0.63% | $100.7$212 |
| ICUI ICU Medical Inc. Common Stock | $4.16B | 139.19 | $162.99 | ▼ 2.54% | $113.37$192.85 |
| NVST Envista Holdings Corporation Common Stock | $4.46B | 39.56 | $22.9 | ▼ 2.55% | $18.77$30.42 |
| HAE Haemonetics Corporation Common Stock | $3.86B | 56.08 | $118.28 | ▼ 2.48% | $48.17$121.19 |
| MMED MiniMed Group Inc. Common Stock | $5.17B | — | $17.49 | ▼ 2.83% | $10.65$24.43 |
| MMSI Merit Medical Systems Inc. Common Stock | $5.24B | 36.33 | $89.2 | ▼ 0.41% | $59.74$94.75 |
| PLSE Pulse Biosciences Inc Common Stock (DE) | $2.65B | — | $44.43 | ▼ 2.54% | $12.56$58.9 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- This Urban Outfitters Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga · 10/16/2026
- Top 3 Healthcare Stocks To Watch In October 2026Yahoo · 10/10/2026
- Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?Yahoo · 10/9/2026
- iRhythm Holdings (IRTC) Disclosed Unauthorized Access To Patient DataYahoo · 10/9/2026
- 2 High-Flying Stocks to Research Further and 1 We QuestionYahoo · 10/8/2026
- 2 Unprofitable Stocks with Competitive Advantages and 1 We Brush OffYahoo · 10/7/2026
- Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $150Benzinga · 10/6/2026
- Here's How Tempus AI is Capitalizing on AI-ECG Market GrowthYahoo · 10/5/2026
- iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home CareYahoo · 10/5/2026
Insider Activity
Insider Actions →- Daniel G. Wilson · September 2, 2026 · Sale773 @ $121.83
- Minang Turakhia · August 10, 2026 · Sale7.1K @ $124.65
- Sumi Shrishrimal · August 10, 2026 · Sale5.4K @ $124.65
- Chad Patterson · August 10, 2026 · Sale7.1K @ $124.65
- Patrick Michael Murphy · August 10, 2026 · Sale7.1K @ $124.65
- Quentin S. Blackford · August 10, 2026 · Sale26.9K @ $124.65
- Minang Turakhia · August 7, 2026 · Grant13.6K
- Sumi Shrishrimal · August 7, 2026 · Grant9.7K
- Chad Patterson · August 7, 2026 · Grant13.6K
- Patrick Michael Murphy · August 7, 2026 · Grant13.6K
- Quentin S. Blackford · August 7, 2026 · Grant48.5K
- Chad Patterson · August 3, 2026 · Sale2.7K @ $122.12
- Julianne Rodda · August 3, 2026 · Sale2.1K @ $122.12
- Mervin Smith · August 3, 2026 · Sale617 @ $122.12
- Sean Clinton Freeman · July 2, 2026 · Sale918 @ $124.71
Institutional Ownership
March 31, 2026
- Total shares held
- 32.91M
- Total value held
- $3.86B
- Institutional holders
- 297
- Unknown2.74M
- Unknown1.67M
- Unknown1.67M
- Unknown1.45M
- Unknown1.45M
- Unknown1.36M
- Unknown1.25M
- Unknown1.05M
- Unknown817.1K
- Unknown788.3K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
iRhythm Reports Data Breach and Completes VitalConnect Acquisition
iRhythm disclosed unauthorized access to patient data, a significant security event for a healthcare company. The firm also completed the acquisition of VitalConnect to expand its cardiac monitoring platform across various care settings. Analyst views remain mixed, with Wells Fargo lowering its price target to $150 while Needham raised its target to $194.
iRhythm Reports Data Breach and Completes VitalConnect Acquisition. iRhythm disclosed unauthorized access to patient data, a significant security event for a healthcare company. The firm also completed the acquisition of VitalConnect to expand its cardiac monitoring platform across various care settings. Analyst views remain mixed, with Wells Fargo lowering its price target to $150 while Needham raised its target to $194.